Pure Biologics
Focused on the biological drug and non-systemic therapies discovery and development.
Launch date
Employees
Wroclaw Lower Silesian Voivodeship (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | - | 41 % | (70 %) | (55 %) | 155 % | (68 %) |
| EBITDA | (<1m) | (<1m) | (1.8m) | (1.6m) | (4.7m) | - |
| % EBITDA margin | (33 %) | (91 %) | (1476 %) | (2979 %) | (3351 %) | - |
| Profit | (<1m) | (<1m) | (2.5m) | (2.6m) | (5.5m) | - |
| % profit margin | (54 %) | (236 %) | (2055 %) | (4632 %) | (3868 %) | - |
| EV / revenue | 19.0x | 26.9x | 315.5x | 573.0x | 73.3x | - |
| EV / EBITDA | -57.8x | -29.6x | -21.4x | -19.2x | -2.2x | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
€90.0k | Grant | ||
€6.7m | Grant | ||
| Total Funding | €6.8m | ||
Related Content
Recent News about Pure Biologics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.